Beth Hoffman
Vermogen: - $ op 31-07-2026
Vermogen: - $ op 31-07-2026
Dr. Beth J.
Hoffman is an Independent Director at Biofrontera, Inc. and a President & Chief Executive Officer at Origami Therapeutics, Inc. She is on the Board of Directors at Biofrontera, Inc. She received her doctorate degree from The Johns Hopkins University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BIOFRONTERA, INC. -.--% | 04-03-2026 | 0 ( -.--% ) | - $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOFRONTERA INC. | Directeur/Bestuurslid | 03-03-2015 |
Origami Therapeutics, Inc.
Origami Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical-stage biopharmaceutical company | Algemeen Directeur | 01-01-2015 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biofrontera, Inc.
Biofrontera, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes dermatological drugs | Health Technology |
Origami Therapeutics, Inc.
Origami Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical-stage biopharmaceutical company | Commercial Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau